Argentine scientist receives R01 grant from the US National Institutes of Health (NIH)

Argentine scientist receives R01 grant from the US National Institutes of Health (NIH) to carry out research on the effect of mHealth on cervical cancer prevention.
Silvina Arrossi, PhD, a CEDES/CONICET researcher and Scientific Coordinator of the National Program for Cervical Cancer Prevention of Argentina’s National Cancer Institute (INC) is the principal investigator in a grant awarded to CEDES by the National Cancer Institute of the National Institutes of Health. The grant is a R01, one of the most prestigious awarded by the NIH. The 3-year research project will be carried out jointly with the INC, Harvard University’s Dana-Farber Cancer Institute, Deakin University (Australia), and the Ministry of Health of Jujuy province.
This project is implemented in Jujuy, a province in the Northern region of the country where a significant percentage of the population has poor access to health, and where self-administered HPV testing has been successfully implemented in the past few years. The research aims at advancing that pioneering experience, by implementing mHealth strategies to improve access of women with HPV self-collected test to their test results, and subsequent follow-up, which are essential in ultimately achieving lower cervical cancer mortality rates.
The use of mobile phone text messages as a tool to facilitate coordination and communication between health system institutions and self-screened HPV+ women can be a cost-effective strategy to advance adherence to the triage process and hence to further increase the success of cervical cancer prevention efforts.
Problems concerning accessibility to the health system are not restricted to cervical cancer diagnosis and treatment. Research results are thus expected to be applicable to a wider spectrum of cancer control and prevention programs in Argentina and internationally.